Related Experiment Videos
Endocrine disorders associated with mutations in guanine nucleotide binding proteins
1Division of Biochemistry and Molecular Biology, University of Glasgow, Scotland, UK.
Bailliere'S Clinical Endocrinology and Metabolism
|January 1, 1996
Summary
Mutations in the GNAS gene, encoding the GNAS alpha protein, cause rare endocrine diseases like AHO. Somatic mutations can lead to mosaicism, affecting clinical features.
Area of Science:
- Endocrinology
- Molecular Genetics
- Human Disease Genetics
Background:
- Rare endocrine diseases present with features of Almond-Halterman-Osebold (AHO) syndrome.
- These conditions are linked to genetic alterations affecting protein expression.
Purpose of the Study:
- Investigate the role of GNAS gene mutations in endocrine disorders.
- Explore the impact of somatic mutations on disease presentation and mosaicism.
Main Methods:
- Genetic analysis of affected individuals and families.
- Biochemical studies using experimental cell models.
Main Results:
- Germline mutations in the GNAS gene cause AHO-related endocrine diseases, with varied mutations observed in different kindreds.
- Somatic mutations in the GNAS gene lead to constitutive activation and potentially decreased protein stability, resulting in mosaicism of clinical features when occurring early in embryogenesis.
Conclusions:
- GNAS gene mutations are the primary cause of specific AHO-related endocrine disorders.
- Alterations in other G-protein alpha subunit genes appear less significant in human disease, despite in vitro evidence of potent effects on cell growth.